ASTX660 Uses, Dosage, Side Effects and more
ASTX660 is under investigation in clinical trial NCT02503423 (Phase 1-2 Study of ASTX660 in Subjects With Advanced Solid Tumors and Lymphomas).
Trade Name | ASTX660 |
Generic | ASTX660 |
Type | |
Formula | C30H42FN5O3 |
Weight | Average: 539.696 Monoisotopic: 539.327168395 |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | January 7, 2025 at 1:49 am |